Hadee AL-KHALİDİ, Abuzer ÇELEKLİ, Zeynel Abidin SAYINER, Mustafa ARAZ

Investigation of the Relationship of Vitamin D, Parathyroid Hormone, Calcium Serum Level, and Insulin Resistance among Obese Individuals

Objective: Several studies have shown that 25-hydroxyvitamin D, parathyroid hormone (PTH), and serum calcium (Ca) may play functional roles with insulin resistance.Methods: This case–control study included 60 obese individuals with impaired fasting glucose who were compared with 60 non-obese individuals with normal fasting glucose who visited the endocrinology and metabolism department. Fasting plasma glu-cose, fasting insulin, triglyceride, PTH, and serum 25-hydroxyvitamin D (25(OH)D) were measured from all subjects in the morning after approximately 8 h of fasting using methods with respect to the standard operating procedures. Homeostatic model assess-ment of insulin resistance (HOMA-IR) was used for determining insulin resistance. The statistical analysis was attained by SPSS.Results: A lack of association was found between serum 25(OH)D and insulin resistance (HOMA-IR) before and after adjusting PTH, Ca, and various variables either in all participants or after exclusion of participants with HOMA-IR ≤2.5. On the other hand, PTH showed a significant inverse correlation with fasting insulin (p=0.022) and HOMA-IR (p=0.023) after adjusting 25(OH)D, serum Ca, and various variables and exclusion of participants with HOMA-IR ≤2.5.Conclusion: In the present study, we did not find a relationship between insulin resistance and vitamin D levels. Further studies are needed for clarifying the relationship between insulin resistance and vitamin D levels.

PDF

___

1. Silver J, Naveh-Many T. Vitamin D and the parathyroid. In Vitamin D, edn 2, Eds D Feldman, F Glorieux & J Wesley Pike. San Diego, Elsevi-er, 2004.
2. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and thera-peutic implications. Endocr Rev 2001; 22: 477-501.[CrossRef ]
3. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in hu-man and rat pancreas. Am J Physiol 1994; 267: E356-60. [CrossRef ]
4. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001; 24: 1496. [CrossRef ]
5. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njøl-stad I, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromso Study 1994- 95 and risk of developing type 2 dia-betes mellitus during 11 years of follow-up. Diabet Med 2010; 27: 1107-15. [CrossRef ]
6. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examina-tion Survey. Diabetes Care 2004; 27: 2813-8. [CrossRef ]
7. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvita-min D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32: 1278-83. [CrossRef ]
8. Chiu KC, Chuang LM, Lee NP, Ryu JM, McGullam JL, Tsai GP, et al. Insulin sensitivity is inversely correlated with plasma intact parathy-roid hormone level. Metabolism 2000; 49: 1501-5. [CrossRef ]
9. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, et al. Prevalence of metabolic syndrome in the general japanese popula-tion in 2000. J Atheroscler Thromb 2006; 13: 202-8.[CrossRef ]
10. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, et al. Vitamin D-3 in fat tissue. Endocr J 2008; 33: 90-4. [CrossRef ]
11. Hedbeack G, Odaen A. Increased risk of death from primary hyper-parathyroidism-an update. Eur J Clin Invest 1998; 28: 271-6. [CrossRef ]
12. Howard G, O’Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996; 93: 1809-17. [CrossRef ]
13. Tremblay A, Gilbert JA. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009; 28: 91-102.[CrossRef ]
14. Zemel MB. Nutritional and endocrine modulation of intracellularcal-cium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem 1998; 188: 129-36. [CrossRef ]